Eli Lilly and Co (NYSE:LLY) under-valued by 13%
| Website | https://www.lilly.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $125,594,075,000 |
| Beta | 0.21783 |
| Average Volume | $3,436,503 |
| Last Dividend | 2.77% |
| Price on Jul 31, 2020 | $131.31 |
| Autochartist™ Valuation | $148.33 |
| Conclusion |
13% under-valued |
| Download Report |
